Magenta Therapeutics, Inc.

MGTA · NASDAQ
Analyze with AI
12/31/2024
12/31/2022
12/31/2021
12/31/2020
Assets
Cash & Equivalents$22,792$57,626$131,650$58,152
Short-Term Investments$252,449$54,415$45,276$90,683
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$5,663$3,561$3,767$2,692
Total Curr. Assets$280,904$115,602$176,926$151,527
Property Plant & Equip (Net)$1,747$29,263$7,461$8,312
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$81,728$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$9,629$1,780$5,547$1,780
Total NC Assets$93,104$31,043$13,008$10,092
Other Assets$0$0$0$0
Total Assets$374,008$146,645$189,934$161,619
Liabilities
Payables$4,579$2,454$3,040$3,760
Short-Term Debt$320$3,824$0$0
Tax Payable$0$0$0$0
Deferred Revenue$479$0$0$0
Other Curr. Liab.$13,074$8,271$7,823$7,670
Total Curr. Liab.$18,452$14,549$10,863$11,430
LT Debt$1,171$26,138$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$1,908$0$6,399$6,283
Total NC Liab.$3,079$26,138$6,399$6,283
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$21,531$40,687$17,262$17,713
Equity
Pref Stock$0$0$0$0
Common Stock$31$61$59$49
Retained Earnings-$174,392-$402,029-$325,567-$254,431
AOCI$106-$181-$30-$23
Other Equity$526,732$508,107$498,210$398,311
Total Equity$352,477$105,958$172,672$143,906
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$374,008$146,645$189,934$161,619
Net Debt-$21,301-$27,664-$131,650-$58,152